Oxurion Provides Update on Clinical Pipeline Progress
Completed Patient Enrollment for Part A of Phase 2 INTEGRAL Trial Evaluating THR-687 for treatment of Diabetic Macular Edema (DME) in treatment naïve...
Source: globenewswire.com
Stay updated with breaking news from Protocol Amendment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Completed Patient Enrollment for Part A of Phase 2 INTEGRAL Trial Evaluating THR-687 for treatment of Diabetic Macular Edema (DME) in treatment naïve...